Clinical Trial

Combination Antibiotic Therapy for Staphylococcus Aureus Bacteremia

Study acronym: COMBAT-SAB
Not Yet Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
The purpose of this study is to see if, in selected patients with a serious bacterial infection of the bloodstream, treating the bacterial infection with a combination of antibiotics is more effective than treating the infection with a single antibiotic. Participants must have blood cultures which are positive for a certain type of bacteria.
Trial Details
NCT Number NCT07376889
Lead Sponsor Intermountain Health Care, Inc.
Conditions Staphylococcus Aureus Bacteremia
Enrollment 2,096 participants
Start Date 2026-02-01
Primary Completion 2029-01 (estimated)
Study Completion 2029-01 (estimated)
Updated on ClinicalTrials.gov 2026-01-29